| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCGENETICS.113.000077 |
| P698 | PubMed publication ID | 23547171 |
| P50 | author | Gerry P McCann | Q56421218 |
| Leong L Ng | Q61120317 | ||
| P2093 | author name string | Lu Zhang | |
| Daniel R Wagner | |||
| Yvan Devaux | |||
| Iain B Squire | |||
| Jennifer Zangrando | |||
| Melanie Vausort | |||
| Dominic Kelly | |||
| Naveed Razvi | |||
| P433 | issue | 3 | |
| P921 | main subject | myocardial infarction | Q12152 |
| microRNA | Q310899 | ||
| ventricular remodeling | Q7920323 | ||
| P304 | page(s) | 290-298 | |
| P577 | publication date | 2013-04-01 | |
| P1433 | published in | Circulation: Cardiovascular Genetics | Q15816430 |
| P1476 | title | MicroRNA-150: a novel marker of left ventricular remodeling after acute myocardial infarction | |
| P478 | volume | 6 |
| Q34962538 | A panel of 4 microRNAs facilitates the prediction of left ventricular contractility after acute myocardial infarction |
| Q51694465 | AT1 receptor blocker azilsartan medoxomil normalizes plasma miR-146a and miR-342-3p in a murine heart failure model. |
| Q57478828 | Abnormal expression of miR‑133a in patients with acute myocardial infarction following radical surgery for gastric cancer and the underlying mechanism |
| Q98394683 | Blood levels of microRNAs associated with ischemic heart disease differ between Austrians and Japanese: a pilot study |
| Q92637466 | Circular RNA-Centered Regulatory Networks in the Physiopathology of Cardiovascular Diseases |
| Q38739402 | Circular RNAs in heart failure |
| Q62494283 | Circular RNAs in the cardiovascular system |
| Q92031522 | Circular RNAs: A Novel Class of Functional RNA Molecules with a Therapeutic Perspective |
| Q92309081 | Circulating MicroRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure |
| Q57477200 | Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study |
| Q33580495 | Circulating miR-208b and miR-34a are associated with left ventricular remodeling after acute myocardial infarction |
| Q55501361 | Circulating miR-30a-5p as a prognostic biomarker of left ventricular dysfunction after acute myocardial infarction. |
| Q35845355 | Circulating microRNAs and Outcome in Patients with Acute Heart Failure |
| Q27001706 | Circulating microRNAs as mirrors of acute coronary syndromes: MiRacle or quagMire? |
| Q33816471 | Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients |
| Q50932525 | Discovery of Potential Therapeutic miRNA Targets in Cardiac Ischemia-Reperfusion Injury |
| Q92889821 | Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy |
| Q35664601 | Expression of circulating miR-486 and miR-150 in patients with acute myocardial infarction |
| Q41965199 | Identification of apoptosis-related microRNAs and their target genes in myocardial infarction post-transplantation with skeletal myoblasts |
| Q63914959 | Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities |
| Q40960619 | Is there a role for microRNAs as novel predictors of prognosis in myocardial infarction? |
| Q47948955 | Knockdown of Long Non-Coding RNA-ZFAS1 Protects Cardiomyocytes Against Acute Myocardial Infarction Via Anti-Apoptosis by Regulating miR-150/CRP. |
| Q33843116 | Lessons from miR-143/145: the importance of cell-type localization of miRNAs |
| Q92216482 | Measurement of circulating natriuretic peptides to identify community-based patients at risk of incident heart failure - should we? |
| Q92597312 | MiR-574-5p: A Circulating Marker of Thoracic Aortic Aneurysm |
| Q90629467 | Micro-RNA 150-5p predicts overt heart failure in patients with univentricular hearts |
| Q42380277 | MicroRNA 150-5p Improves Risk Classification for Mortality within 90 Days after Acute Ischemic Stroke. |
| Q35661827 | MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death |
| Q91810467 | MicroRNAs as Prognostic Markers in Acute Coronary Syndrome Patients-A Systematic Review |
| Q38110225 | MicroRNAs as biomarkers for ischemic heart disease |
| Q47926697 | MicroRNAs as potential prognosticators of neurological outcome in out-of-hospital cardiac arrest patients |
| Q33821302 | MicroRNAs expression profiles in cardiovascular diseases |
| Q35071551 | MicroRNAs: new biomarkers and therapeutic targets after cardiac arrest? |
| Q26785405 | MicroRNAs; easy and potent targets in optimizing therapeutic methods in reparative angiogenesis |
| Q88482868 | Non-coding RNAs as biomarkers for acute myocardial infarction |
| Q46252008 | Non-coding RNAs in cardiovascular disease: pathological relevance and emerging role as biomarkers and therapeutics |
| Q89419879 | Noncoding RNAs in disease |
| Q50068138 | Overexpressing microRNA-150 attenuates hypoxia-induced human cardiomyocyte cell apoptosis by targeting glucose-regulated protein-94. |
| Q55381244 | Plasma Circulating Extracellular RNAs in Left Ventricular Remodeling Post-Myocardial Infarction. |
| Q64953779 | Plasma miR-22-5p, miR-132-5p, and miR-150-3p Are Associated with Acute Myocardial Infarction. |
| Q28545216 | Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis |
| Q50067467 | Platelet microRNA for predicting acute myocardial infarction |
| Q92881879 | Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection |
| Q50105196 | Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction |
| Q26739721 | Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease |
| Q38263602 | ST elevation myocardial infarction: recent advances and updates. |
| Q41095618 | Serum microRNA-1233 is a specific biomarker for diagnosing acute pulmonary embolism |
| Q37236462 | Study to Improve Cardiovascular Outcomes in high-risk older patieNts (ICON1) with acute coronary syndrome: study design and protocol of a prospective observational study |
| Q33677280 | Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction |
| Q35888026 | The biology of circulating microRNAs in cardiovascular disease. |
| Q47233677 | The circular RNA MICRA for risk stratification after myocardial infarction |
| Q27309112 | Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice. |
| Q37443465 | Which future for circulating microRNAs as biomarkers of acute myocardial infarction? |
| Q38734588 | miR-181a and miR-150 regulate dendritic cell immune inflammatory responses and cardiomyocyte apoptosis via targeting JAK1-STAT1/c-Fos pathway |
| Q51258747 | miR-539 as a key negative regulator of the MEK pathway in myocardial infarction. |
| Q38669417 | miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204. |
| Q38268457 | miRNAs in post-ischaemic angiogenesis and vascular remodelling |
| Q27028108 | miRNome in myocardial infarction: Future directions and perspective |
| Q38629524 | microRNA expression changes after atrial fibrillation catheter ablation |
| Q38379481 | microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts |
Search more.